Literature DB >> 11140834

The causes and consequences of random and non-random X chromosome inactivation in humans.

C J Brown1, W P Robinson.   

Abstract

X chromosome (X) inactivation is a remarkable biological process including the choice and cis-limited inactivation of one X, as well as the stable maintenance of this silencing by epigenetic chromatin alterations. The process results in females generally being mosaic for two populations of cells--one with each parental X active. In this review, we discuss recent advances in our understanding of how inactivation works, as well as the causes and clinical implications of deviations from random inactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140834     DOI: 10.1034/j.1399-0004.2000.580504.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  35 in total

1.  The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription.

Authors:  Yonggang Zhou; Raffaella Santoro; Ingrid Grummt
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

Review 3.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

4.  Extreme skewing of X chromosome inactivation in mothers of homosexual men.

Authors:  Sven Bocklandt; Steve Horvath; Eric Vilain; Dean H Hamer
Journal:  Hum Genet       Date:  2005-12-21       Impact factor: 4.132

5.  The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy.

Authors:  Xin Chen; Sergei P Shevtsov; Eileen Hsich; Lei Cui; Syed Haq; Mark Aronovitz; Risto Kerkelä; Jeffery D Molkentin; Ronglih Liao; Robert N Salomon; Richard Patten; Thomas Force
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  High frequency of skewed X inactivation in young breast cancer patients.

Authors:  M Kristiansen; A Langerød; G P Knudsen; B L Weber; A L Børresen-Dale; K H Orstavik
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

7.  Cardiovascular Diseases, Aging and the Gender Gap in the Human Longevity.

Authors:  Abraham Aviv
Journal:  J Am Soc Hypertens       Date:  2007-06

Review 8.  Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Authors:  Louise L C Pinto; Taiane A Vieira; Roberto Giugliani; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

9.  X-chromosome inactivation patterns in monozygotic twins and sib pairs discordant for nonsyndromic cleft lip and/or palate.

Authors:  Jane W Kimani; Min Shi; Sandra Daack-Hirsch; Kaare Christensen; Danilo Moretti-Ferreira; Mary L Marazita; L Leigh Field; John W Canady; Jeffrey C Murray
Journal:  Am J Med Genet A       Date:  2007-12-15       Impact factor: 2.802

Review 10.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.